NO990335L - Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling - Google Patents
Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstillingInfo
- Publication number
- NO990335L NO990335L NO990335A NO990335A NO990335L NO 990335 L NO990335 L NO 990335L NO 990335 A NO990335 A NO 990335A NO 990335 A NO990335 A NO 990335A NO 990335 L NO990335 L NO 990335L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- compounds
- rlt
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/12—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9602889A SE9602889D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
SE9602890A SE9602890D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
SE9602888A SE9602888D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
SE9602887A SE9602887D0 (sv) | 1996-07-29 | 1996-07-29 | Carboxylic esters, their use and preparation |
PCT/SE1997/001310 WO1998004517A1 (en) | 1996-07-29 | 1997-07-23 | Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO990335D0 NO990335D0 (no) | 1999-01-25 |
NO990335L true NO990335L (no) | 1999-03-29 |
Family
ID=27484794
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO990335A NO990335L (no) | 1996-07-29 | 1999-01-25 | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling |
Country Status (17)
Country | Link |
---|---|
US (1) | US6124354A (zh) |
EP (1) | EP0923536A1 (zh) |
JP (1) | JP2000515881A (zh) |
KR (1) | KR20000029703A (zh) |
CN (1) | CN1226886A (zh) |
AU (1) | AU724563B2 (zh) |
BG (1) | BG103207A (zh) |
BR (1) | BR9710614A (zh) |
CA (1) | CA2261692A1 (zh) |
EE (1) | EE9900034A (zh) |
IL (1) | IL128096A0 (zh) |
NO (1) | NO990335L (zh) |
NZ (1) | NZ333798A (zh) |
PL (1) | PL331384A1 (zh) |
SK (1) | SK4699A3 (zh) |
TR (1) | TR199900185T2 (zh) |
WO (1) | WO1998004517A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020547A1 (es) | 2000-10-24 | 2002-06-12 | Upjohn Co | Uso de la tolterodina en tratamientos del asma |
BR0206300A (pt) * | 2001-11-05 | 2008-04-08 | Upjohn Co | composição farmacêutica para tratar distúrbio urinário em um mamìfero e uso |
US8481518B2 (en) * | 2003-01-16 | 2013-07-09 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
WO2008059239A1 (en) * | 2006-11-14 | 2008-05-22 | Astrazeneca Ab | Novel compounds 514 |
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
JP4837800B2 (ja) | 2008-05-13 | 2011-12-14 | アストラゼネカ・アクチエボラーグ | ムスカリンm3受容体アンタゴニストとしてのキヌクリジン誘導体 |
KR20110010725A (ko) * | 2008-05-13 | 2011-02-07 | 아스트라제네카 아베 | 무스카린성 수용체 길항제 및 β2아드레날린수용체 효능제를 포함하는 제약 생성물 |
EP2699539B1 (en) * | 2011-04-21 | 2019-03-06 | Emory University | Cyclopropyl derivatives and methods of use |
JOP20130273B1 (ar) | 2012-09-11 | 2021-08-17 | Genzyme Corp | مثبطات انزيم (سينثاز) غلوكوسيل سيراميد |
TW201517906A (zh) | 2013-07-25 | 2015-05-16 | Almirall Sa | 含有maba化合物和皮質類固醇之組合 |
TW201617343A (zh) * | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | 具有β2腎上腺素促效劑及M3蕈毒拮抗劑活性之新穎雙環衍生物 |
CN106083615B (zh) * | 2016-06-08 | 2019-03-08 | 山东省药学科学院 | 一种盐酸环喷托酯的制备方法 |
JP7134173B2 (ja) | 2017-06-21 | 2022-09-09 | 第一三共株式会社 | Ep300/crebbp阻害剤 |
MX2023001014A (es) | 2020-07-24 | 2023-03-01 | Genzyme Corp | Composiciones farmaceuticas que comprenden venglustat. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2168881A1 (en) * | 1972-01-25 | 1973-09-07 | Synthelabo | Tropanol 1-phenylcycloalkane carboxylic ester salts - spasmolytics and cholinergics |
US4418202A (en) * | 1981-12-21 | 1983-11-29 | Emery Industries, Inc. | 2-Vinyl- and 2-ethylcyclopropane monocarboxylates |
DD289411A7 (de) * | 1984-06-29 | 1991-05-02 | Arzneimittelwerk Dresden Gmbh,De | Verfahren zur herstellung eines antidos fuer phosphororganische verbindungen |
IT1228293B (it) * | 1989-02-06 | 1991-06-07 | Angeli Inst Spa | Benzoderivati di composti eterociclici contenenti azoto. |
US5086054A (en) * | 1990-07-31 | 1992-02-04 | Sri International | Novel arylcycloalkanepolyalkylamines |
US5064850A (en) * | 1991-04-08 | 1991-11-12 | Marion Merrell Dow Inc. | Dihydro-3,3-diphenyl-5-(1H-pyrazol-1-ylmethyl-2(3H)-furanone and dihydro-5-((substituted-1H-pyrazol-1-yl)methyl)-3,3-diphenyl-2(3H)-furanone derivatives |
US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
-
1997
- 1997-07-23 IL IL12809697A patent/IL128096A0/xx unknown
- 1997-07-23 WO PCT/SE1997/001310 patent/WO1998004517A1/en not_active Application Discontinuation
- 1997-07-23 TR TR1999/00185T patent/TR199900185T2/xx unknown
- 1997-07-23 US US09/230,164 patent/US6124354A/en not_active Expired - Fee Related
- 1997-07-23 CA CA002261692A patent/CA2261692A1/en not_active Abandoned
- 1997-07-23 PL PL97331384A patent/PL331384A1/xx unknown
- 1997-07-23 AU AU37905/97A patent/AU724563B2/en not_active Ceased
- 1997-07-23 JP JP10508739A patent/JP2000515881A/ja active Pending
- 1997-07-23 EP EP97934832A patent/EP0923536A1/en not_active Withdrawn
- 1997-07-23 BR BR9710614-3A patent/BR9710614A/pt unknown
- 1997-07-23 SK SK46-99A patent/SK4699A3/sk unknown
- 1997-07-23 CN CN97196892A patent/CN1226886A/zh active Pending
- 1997-07-23 KR KR1019997000803A patent/KR20000029703A/ko not_active Application Discontinuation
- 1997-07-23 NZ NZ333798A patent/NZ333798A/xx unknown
- 1997-07-23 EE EEP199900034A patent/EE9900034A/xx unknown
-
1999
- 1999-01-25 NO NO990335A patent/NO990335L/no not_active Application Discontinuation
- 1999-02-25 BG BG103207A patent/BG103207A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU3790597A (en) | 1998-02-20 |
CN1226886A (zh) | 1999-08-25 |
NZ333798A (en) | 2000-08-25 |
JP2000515881A (ja) | 2000-11-28 |
AU724563B2 (en) | 2000-09-28 |
SK4699A3 (en) | 2000-04-10 |
CA2261692A1 (en) | 1998-02-05 |
EP0923536A1 (en) | 1999-06-23 |
KR20000029703A (ko) | 2000-05-25 |
BG103207A (en) | 1999-10-29 |
EE9900034A (et) | 1999-08-16 |
PL331384A1 (en) | 1999-07-05 |
IL128096A0 (en) | 1999-11-30 |
NO990335D0 (no) | 1999-01-25 |
BR9710614A (pt) | 2000-01-11 |
TR199900185T2 (xx) | 1999-04-21 |
US6124354A (en) | 2000-09-26 |
WO1998004517A1 (en) | 1998-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO990335L (no) | Arylsykloalkankarboksylestere, anvendelse derav, farmas°ytiske sammensetninger og fremstilling | |
RU95108387A (ru) | Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина | |
NO982913L (no) | Kinolin- og kinazolinforbindelser nyttige i terapi | |
DK135791D0 (da) | 1h-imidazooe4,5-caaquinolin-4-amin, farmaceutisk praeparat indeholdende en saadan forbindelse og fremga ngsmaade til fremstilling af forbindelsen | |
ES8106722A1 (es) | Un metodo para la preparacion de derivados de ftalimidina | |
ATE139783T1 (de) | Azasteroide zur behandlung prostatischer hypertrophie, ihre herstellung und verwendung | |
MY104376A (en) | N-imidazolyl deravatives of bicyclic compounds and process for their preparation. | |
UA41290C2 (uk) | Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті | |
MY123467A (en) | Preparation of sterically hindered amine ethers | |
BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
NO953254L (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
DE69511260D1 (en) | Bicyclische amidinderivate als no-synthetase inhibitoren | |
ES8505518A1 (es) | Procedimiento para preparar derivados de aminoacidos | |
SE7501365L (zh) | ||
ES2061966T3 (es) | Mejoras introducidas en la sintesis de derivados 6-metilenicos de androsta-1,4-dieno-3,17-diona. | |
DK0763024T3 (da) | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater | |
DK0383686T3 (da) | Carboxyalkylethere af 2-amino-7-hydroxytetralin samt fremgangsmåde til fremstilling deraf | |
TW238304B (en) | A process for the preparation of 1-substituted-5(4H)-tetrazolinones | |
CS180191A3 (en) | Novel derivatives of oxazole, process for their preparation and pharmaceuticals containing them | |
MXPA04003568A (es) | Aralquil-tetrahidro-piridinas su preparacion y composiciones farmaceuticas que contienen las mismas. | |
ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
MY104955A (en) | Pyrroloquinoline and pyrrolophemothiazine carboxamides and related compounds. | |
NO982549L (no) | 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav | |
ES8701762A1 (es) | Un procedimiento para preparar nuevos derivados de 5-(w-fe- netilamino-alquil)-4,5,6,7-tetrahidro-tieno-(3,2-c)-piridina | |
MX9601163A (es) | Nuevos compuestos derivados de cromeno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |